Skip to content

PCORI-CER-1306-03385 Lung Cancer Screening Decision Aid Development and Testing

Promoting Informed Decisions About Lung Cancer Screening: Decision Aid Update and Measures Development

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02282969
Enrollment
620
Registered
2014-11-05
Start date
2014-07-11
Completion date
2028-08-31
Last updated
2026-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Knowledge, Attitudes, Practice

Keywords

Cancer Prevention, Smokers, Quit smoking, Interviews, Questionnaires, Surveys, Lung cancer screening, Patient decision aid

Brief summary

Objectives: This protocol addresses the first phase of a larger project funded by the Patient-Centered Outcomes Research Institute to help heavy smokers make informed decisions about lung cancer screening with low-dose computed tomography (CT). A separate IRB protocol will be submitted for the larger, comparative study. In this initial development phase, our prototype patient decision aid will be updated to reflect current guidelines about lung cancer screening. The updated aid will then be pilot-tested in a new sample of patients. In addition, several of the study measures will be refined and further developed in preparation for the larger study. The specific aims of the measures and decision aid development phase of this project are as follows: Update the aid to reflect current screening guidelines and refine the aid via cognitive testing with patients/smokers; and pilot test the updated aid for acceptability with patients/smokers. Modify our current measure of lung cancer knowledge, conduct cognitive testing of the new measure with patients/smokers, and evaluate the reliability of the new measure in a sample patients/smokers.

Detailed description

Cognitive and Pilot Testing: If you agree to take part in this study, you will take part in an interview with a member of the research staff. The interviewer will take notes of your responses. First, you will be asked some questions about you, like your age, sex, race, and education level. Then you will be asked to look at some educational materials about lung cancer screening. These could be written information, animations, graphics, videos, or questionnaires. You may be asked questions about: * Lung cancer and lung cancer screening * The length of the materials * The balance of the information found in the materials The study interview will take place in person at MD Anderson and will take between 1 and 1 ½ hours. Your participation on this study will be over once the interview is complete. This is an investigational study. Up to 50 participants will be enrolled in this part of the study. All will take part at MD Anderson, UTMB, the Galveston community, or tobacco-related community events. Measures Reliability Study: If you agree to take part in this study, you will complete a questionnaire 2 times. The questionnaire will ask about: * Lung cancer * Lung cancer screening * Making decisions about screening * Your age, race, gender, and level of education You will complete the first questionnaire in person. It will take about 20 minutes to fill out. Then, about 1 month later, you will be asked to fill out the questionnaire again. The second time you can come in person, or fill out the questionnaire by mail or telephone. Your participation will be over when the second questionnaire is complete. This is an investigational study. Up to 150 participants will be enrolled in this part of the study. All will take part at MD Anderson, UTMB, the Galveston community, or tobacco-related community events.

Interventions

BEHAVIORALInterviews

Interviews performed by study staff encompassing lung cancer screening and patient decision aids.

BEHAVIORALQuestionnaires

Questionnaires completed after viewing patient decision aid video. Questionnaires also completed regarding lung cancer screening knowledge at first visit, then again in one month.

Sponsors

M.D. Anderson Cancer Center
Lead SponsorOTHER
Patient-Centered Outcomes Research Institute
CollaboratorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
55 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

1. Men and women 55 to 80 years of age. 2. Participants must speak English. 3. Current smoker or quit smoking within the past 15 years.

Exclusion criteria

1\. History of lung cancer.

Design outcomes

Primary

MeasureTime frameDescription
Informed Decisions About Lung Cancer Screening (Data from interviews and questionnaires reviewed to assess participant knowledge)1 MonthData from interviews and questionnaires reviewed to assess participant knowledge regarding lung cancer screening and decision aid.

Countries

United States

Contacts

CONTACTRobert Volk, PHD
BVolk@mdanderson.org713-563-2509
STUDY_CHAIRRobert Volk, PHD

M.D. Anderson Cancer Center

PRINCIPAL_INVESTIGATORSuzanne Linder, PHD

The University of Texas Medical Branch at Galveston

PRINCIPAL_INVESTIGATORPaul Cinciripini, PHD, MS, BS

M.D. Anderson Cancer Center

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 17, 2026